These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2068835)

  • 1. Quinapril: a new second-generation ACE inhibitor.
    Cetnarowski-Cropp AB
    DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis.
    Swartz RD; Starmann B; Horvath AM; Olson SC; Posvar EL
    J Clin Pharmacol; 1990 Dec; 30(12):1136-41. PubMed ID: 2273086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
    Vertes V; Haynie R
    Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.
    Begg EJ; Robson RA; Bailey RR; Lynn KL; Frank GJ; Olson SC
    Br J Clin Pharmacol; 1990 Aug; 30(2):213-20. PubMed ID: 2144994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure.
    Begg EJ; Robson RA; Ikram H; Richards AM; Bammert-Adams JA; Olson SC; Posvar EL; Reece PA; Sedman AJ
    Br J Clin Pharmacol; 1994 Mar; 37(3):302-4. PubMed ID: 8198942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of quinapril, a new ACE inhibitor.
    Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application.
    Kieback AG; Felix SB; Reffelmann T
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1337-47. PubMed ID: 19761414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.
    Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E
    J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.
    Blum RA; Olson SC; Kohli RK; Horvath AM; Sedman AJ; Posvar EL
    J Clin Pharmacol; 1990 Oct; 30(10):938-42. PubMed ID: 2229454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of hypertension in older patients.
    Schnaper HW
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S56-61. PubMed ID: 1691408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and tolerability of quinapril.
    Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders.
    Wadworth AN; Brogden RN
    Drugs; 1991 Mar; 41(3):378-99. PubMed ID: 1711445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
    Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
    Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibitors in the treatment of hypertension in the older patient.
    Canter D; Frank G
    Eur Heart J; 1990 May; 11 Suppl D():33-43. PubMed ID: 2193809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinapril: overview of preclinical data.
    Kaplan HR; Taylor DG; Olson SC
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII6-12. PubMed ID: 2189623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.